专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

61. 发明公开

EP1495763A4 THERAPEUTIC CREAM FOR DERMATITIS 有权
标题翻译：治疗性CREAM皮炎
公开(公告)号：EP1495763A4
公开(公告)日：2006-07-05
申请号：EP02718592
申请日：2002-04-15
申请人： SANTO TETSUO
发明人： SANTO TETSUO , LI SONGHUA , WANG RUWEI , IWASAKI SUMIO
IPC分类号： A61K8/97 , A61K31/10 , A61K31/16 , A61K31/60 , A61K36/185 , A61K36/232 , A61K36/234 , A61K36/315 , A61K36/484 , A61K36/489 , A61K36/539 , A61K36/575 , A61K36/65 , A61K36/704 , A61K36/752 , A61K36/756 , A61K36/9066 , A61P7/00 , A61P17/00 , A61Q19/00 , A61K35/78 , A61K7/00 , A61K7/48
CPC分类号： A61Q19/00 , A61K8/97 , A61K31/10 , A61K31/16 , A61K31/60 , A61K36/185 , A61K36/232 , A61K36/234 , A61K36/315 , A61K36/484 , A61K36/489 , A61K36/539 , A61K36/575 , A61K36/65 , A61K36/704 , A61K36/752 , A61K36/756 , A61K36/9066 , A61K2300/00
摘要： Technical Field: A therapeutic cream for dermatitis. Technical Problems: To provide a therapeutic cream efficacious for atopic dermatitis. Means for Resolution: Having a composition of 3% of Sophora radix, 2% of Curcuma aromatisca, 2% of Magnoliae cortex, 2% of Montan cortex, 1% of Baphicacanthes cusia, 1% of Borneolum syntheticum, 2% of Scutellariae radix, 2% of Phellodendri cortex, 1% of Angellica dahurica, 3% of lemon, 2% of Polygonum cuspidatum, 0.5% of Glycyrrhizae radix, 0.5% of Chidii rhizoma, 0.5% of Angelica acutiloba, 0.5% of salicylic acid, 0.5% of resorcin, 3% of lanoline, 3% of alcohol and 70.5% of white petrolactum. Owing to synergistic action of the antibacterial, antiviral, antiallergic, antiinflammtory, blood circulation-accelerating, antifungal, sterilizing and antipruritic effects of the above-described components, the effect of accelerating the penetration of active ingredients into the deep part under the skin of Chidii rhizoma and Angelica acutiloba, and the cornificaiton-accelerating effects of salicylic acid and resorcin, various dermatites such as atopic dermatitis can be innovatively treated. Major use: To be used in treating dermatitis, in particular, atopic dermatitis.

62. 发明公开

EP1594516A1 HERBAL COMPOSITIONS FOR PROSTATE CONDITIONS 有权
标题翻译：中药复方前列腺莱顿
公开(公告)号：EP1594516A1
公开(公告)日：2005-11-16
申请号：EP04702894.9
申请日：2004-01-16
申请人： Healthaid Enterprise Pte. Ltd.
发明人： KUOK, Koon, Yong , LY, Hien
IPC分类号： A61K35/78 , A61P13/08
CPC分类号： A61K36/899 , A23L33/105 , A61K36/07 , A61K36/074 , A61K36/076 , A61K36/11 , A61K36/185 , A61K36/232 , A61K36/233 , A61K36/237 , A61K36/25 , A61K36/268 , A61K36/324 , A61K36/328 , A61K36/36 , A61K36/428 , A61K36/46 , A61K36/48 , A61K36/481 , A61K36/484 , A61K36/539 , A61K36/54 , A61K36/62 , A61K36/64 , A61K36/65 , A61K36/68 , A61K36/708 , A61K36/71 , A61K36/714 , A61K36/716 , A61K36/744 , A61K36/756 , A61K36/804 , A61K36/882 , A61K36/884 , A61K36/8945 , A61K36/8964 , A61K36/8965 , A61K36/8994 , A61K38/09 , A61K2300/00
摘要： Methods and compositions are disclosed for prevention or treatment of prostate disorders and ameliorating thereof, including prostatitis, benign prostate hyperplasia and prostatic carcinoma. The methods comprise administering a composition of matter comprising the following herbal and other components: Radix Asparagi; Radix Angelicae Pubescentis; Radix Tricliosatithis; Radix Scuttellariae; Radix Angelicae Sinensis; Radix Dipsaci; Cortex Eucommiae; Medulla Junci; Rhizoma Anemarrhenae; Caulis Akebiae; Herba Dianthi; Semen Plantaginis; Cortex Phellodendri (fried); Radix et Rhizoma Rhei; Rhizoma seu Radix Notopterygii; Olibanum; Fructus Gardeniac; Radix Astragali seu Hedysari; Rhizonia Cimiciffigac; Radix Bupleuri; Myrrha; Gypsum Fibrosun; Radix Rehamatmiae (crude); Folium Pyrrosiae; Rhizoma Acori Graminei; Rhizoma Dioscoreae Hypoglaucae; Radix Linderae; Herba Cistanche; Radix Paeoniae Rubra; Rhizoma Dioscoreae; Semen Euryales; Cortex Mouton; Polyporus Umbetlatus; Radix Rehmanniae Praeparata; Medulla Tetrapanacis; Semen Coicis; Fructus Horedi Germinatus (Poria); Radix Aconiti Praeparata; Rbizoma Alismatis; Cortex Cinnamomi; Herba Asari; Radix Glycyrrhizae; Stigma Maydis; Phaseolus Radiatus L., and optionally, Ganoderma Lucidum.

63. 发明公开

EP1541161A1 TABLET COMPOSITION CONTAINING CHINESE ORTHODOX MEDICINE EXTRACT AND PROCESS FOR PRODUCING THE SAME 有权
标题翻译：随着对生产中国正统医学提取和处理片剂组成
公开(公告)号：EP1541161A1
公开(公告)日：2005-06-15
申请号：EP03741313.5
申请日：2003-07-10
申请人： TSUMURA & CO.
发明人： MATSUMOTO, Kazuhiro , MARUYAMA, Hideyuki , NAGANO, Yoshihiko , ISHIMARU, Masayuki
IPC分类号： A61K35/78 , A61K45/00 , A61K9/20 , A61K47/04 , A61K47/38 , A61K47/46 , A61K47/48 , A61P43/00
CPC分类号： A61K45/06 , A61K9/2009 , A61K9/2054 , A61K33/00 , A61K36/076 , A61K36/185 , A61K36/232 , A61K36/233 , A61K36/258 , A61K36/481 , A61K36/488 , A61K36/54 , A61K36/65 , A61K36/708 , A61K36/718 , A61K2300/00
摘要： A Kampo medicinal extract-containing tablet composition contains a Kampo medicinal extract powder, cellulose glycolate and sodium hydrogen carbonate. It preferably further contains silicic anhydride. A process to manufacture a Kampo medicinal extract-containing tablet composition by the step of adding silicic anhydride and water to a Kampo medicinal extract powder, stirring and granulating the mixture, and the step of mixing the granulated substance with cellulose glycolate and sodium hydrogen carbonate. The Kampo medicinal extract-containing tablet composition can be satisfactorily disintegrated and dissolved and a process for manufacturing the same, by formulating specific compounds to a Kampo medicinal extract powder.
摘要翻译：甲汉方药用含提取物的片剂组合物中含有药用汉方提取物粉末，甘醇酸纤维素和碳酸氢钠。它优选包含另外的硅酸酐。的方法，通过添加硅酸酐和水的汉方药材提取物粉末，搅拌和粒化所述混合物的步骤，以及与甘醇酸纤维素和碳酸氢钠的造粒物混合的步骤，以制造汉方药用含提取物的片剂组合物。汉方药用含提取物的片剂组合物可令人满意地崩解，溶解的和制造方法，通过特定的化合物配制到汉方药材提取物粉末的方法。

64. 发明公开

EP1495762A1 THERAPEUTIC LOTION FOR DERMATITIS 有权
标题翻译：治疗脂肪酸摄入量
公开(公告)号：EP1495762A1
公开(公告)日：2005-01-12
申请号：EP02717158.6
申请日：2002-04-15
申请人： Santo, Tetsuo
发明人： SANTO, Tetsuo , LI, Songhua , WANG, Ruwei , IWASAKI, Sumio
IPC分类号： A61K35/78 , A61K31/10 , A61K31/16 , A61K7/00 , A61K7/48 , A61P17/00 , A61P7/00
CPC分类号： A61K36/575 , A61K31/10 , A61K31/16 , A61K36/185 , A61K36/315 , A61K36/48 , A61K36/65 , A61K36/9066 , A61K2300/00
摘要： TECHNICAL FIELD: Lotion for therapy of dermatitis
TECHNICAL PROBLEM: To provide a lotion for therapy effective against atopic dermatitis.
MEANS FOR SOLVING: It has a composition: Lightyellow Sophora Root, 3%; Turmeric, 2%; Magnolia Bark, 2%; Moutan Bark, 2%; Isatis Leaf, 1%; Borneo Camphor Tree (Dryobalanops aromatica Gaertn.f.), 1%; Amur Cork Tree, 2%; Angelicae Dahuricae Root, 1%; Lemon, 3%; Smartweed, 2%; Licorice, 0.5%; Cnidii Rhizoma, 0.5%; Japanese Angelica Root, 0.5%; salicylic acid, 0.5%; resorcinol, 0.5%; alcohol, 30%; and water, 48.5%.
A significant therapeutic effect against atopic dermatitis is obtained by a synergistic effect between antibacterial, antiviral, antiallergic, antiphlogistic, and blood-circulation accelerating actions as pharmacological effects of Lightyellow Sophora Root, Turmeric, Magnolia Bark, Moutan Bark, Isatis Leaf, Borneo Camphor Tree (Dryobalanops aromatica Gaertn.f.), Amur Cork Tree, Angelicae Dahurikae Root, Lemon, Smartweed, and Licorice, accelerating action for skin permeation and antifungal-sterilizing action of Cnidii Rhizoma and Japanese Angelicae Root, accelerating action for keratinization and antifungal-sterilizing action of salicylic acid and resorcinol, as described above.
Principal Use: It is used for the therapy of dermatitis, particularly of atopic dermatitis.
摘要翻译：技术领域：用于治疗皮炎的乳液技术问题：提供一种治疗有效抵抗特应性皮炎的治疗剂。解决方法：它有一个组成：Lightyellow Sophora Root，3％; 姜黄，2％; 木兰树皮2％; 木桐树皮2％; Is叶1％; 婆罗洲樟树（Dryobalanops aromatica Gaertn.f。），1％; 阿穆尔软木树，2％; 当归Dahuricae根，1％; 柠檬，3％ Smartweed，2％; 甘草，0.5％; Cnidii Rhizoma，0.5％; 日本当归根，0.5％; 水杨酸，0.5％; 间苯二酚，0.5％; 酒精，30％; 和水，48.5％。通过抗菌，抗病毒，抗过敏，消炎和血液循环加速作用之间的协同作用，获得了对特应性皮炎的显着治疗作用，作为Lightyellow Sophora Root，姜黄，木兰树皮，Moutan Bark，Isatis Leaf的药理作用，婆罗洲樟树（Dryobalanops aromatica Gaertn.f。），阿穆尔软木树，当归Dahurikae根，柠檬，仙妮草和甘草，加速ii for和日本当归的皮肤渗透和抗真菌灭菌作用，加速角化作用和水杨酸和间苯二酚的抗真菌灭菌作用。主要用途：用于治疗皮炎，特别是特应性皮炎。

65. 发明授权

EP0772447B1 CHINESE HERBS EXTRACT 失效
标题翻译：提取物及中药复方的
公开(公告)号：EP0772447B1
公开(公告)日：2003-09-03
申请号：EP95922645.7
申请日：1995-06-23
申请人： PHYTOTECH LIMITED
发明人： WHITTLE, Brian Anthony , LATCHMAN, Yvette , BROSTOFF, Jonathan
IPC分类号： A61K35/78 , G01N33/50 , G01N33/577
CPC分类号： A61K36/804 , A61K36/00 , A61K36/185 , A61K36/238 , A61K36/48 , A61K36/484 , A61K36/538 , A61K36/65 , A61K36/716 , A61K36/73 , A61K36/75 , A61K36/899 , Y10S514/861 , Y10S514/863 , Y10S514/885 , Y10S514/886 , Y10S514/887 , A61K2300/00
摘要： A material suitable for the treatment of atopic disease, non-atopic eczema or psoriasis is described which can be extracted from a freeze-dried decoction of a mixture comprising the following Chinese herbs: Radix Ledebouriella, Fructus Tribuli, Herba Potentilla chinensis, Caulis Clematis armandii, Radix Rehmannia, Radix Glycyrrhiza, Radix Paeonia rubra, Cortex Dictamni radicis, Herba Lopatheri, Spica Schizonepetae, said material comprising one or more of those components present in the freeze-dried decoction which run with Rf values in the ranges 0.00 to 0.100, 0.167 to 0.300, 0.400 to 0.533, 0.700 to 0.833 or 0.900 to 0.967 if said freeze-dried decoction is diluted in aqueous solution and subjected to chromatography on a Whatman 2cms x 55cms x 3mm cellulose strip for 10 hours using a solvent mixture of butanol, ethanol and water in the proportions 4:1:1.

66. 发明公开

EP1331007A2 Chinese herbs extract 失效
标题翻译：中药提取物
公开(公告)号：EP1331007A2
公开(公告)日：2003-07-30
申请号：EP03007490.0
申请日：1995-06-23
申请人： Phytotech Limited
发明人： Whittle, Brian Anthony
IPC分类号： A61K35/78 , A61P17/00 , A61P17/06
CPC分类号： A61K36/804 , A61K36/00 , A61K36/185 , A61K36/238 , A61K36/48 , A61K36/484 , A61K36/538 , A61K36/65 , A61K36/716 , A61K36/73 , A61K36/75 , A61K36/899 , Y10S514/861 , Y10S514/863 , Y10S514/885 , Y10S514/886 , Y10S514/887 , A61K2300/00
摘要： A composition for the treatment of a disease selected from the group consisting of atopic disease, non-atopic eczema and psoriasis is described, which comprises a decoction or extract obtained from a subset of the set of herbs consisting of: Radix Ledebouriella, Fructus Tribuli, Herba Potentilla Chinensis, Caulis Clematis Armandii, Radix Rehmannia, Radix Glycyrrhiza, Radix Paeonia Rubra, Cortex Dictamni Radicis, Herba Lopatheri, Spika Schizonepetae, in the substantial absence of any other herb; said decoction or extract comprising one or more of those components present in fractions which run with Rf values in the ranges: 0.00 to 0.100; 0.167 to 1.300; 0.400 to 0.533; 0.700 to 0.833; or 0.900 to 0.967 if an aqueous solution of a freeze-dried decoction of said set of herbs is subjected to chromatography on a Whatman 2cms x 55cms 3MM cellulose strip for 10 hours using a solvent mixture of butanol, ethanol and water in the proportions 4:1:1.
摘要翻译：描述了用于治疗选自特应性疾病，非特应性湿疹和牛皮癣的疾病的组合物，其包含从该组草药的子集获得的煎剂或提取物，所述草药组由以下各项组成：莱氏枸杞，F蒿，在基本不存在任何其他草药的情况下，中草药，枸杞，铁线莲，生地黄，甘草，芍药，杜鹃花，草本植物，Spika Schizonepetae; 所述煎煮或提取物包含存在于以Rf值在0.00至0.100范围内的级分中存在的那些组分中的一种或多种： 0.167至1.300; 0.400至0.533; 0.700至0.833; 或如果所述一组草药的冻干水煎液的水溶液在Whatman 2cm×55cm 3MM纤维素条上进行层析10小时，使用丁醇，乙醇和水的比例为4:1的溶剂混合物， 1：1。

67. 发明公开

EP1287828A1 Composition of health food for prophylaxis and treatment of constipation 审中-公开
标题翻译：的药用食物成分对便秘的预防和治疗
公开(公告)号：EP1287828A1
公开(公告)日：2003-03-05
申请号：EP01119755.5
申请日：2001-08-28
申请人： Han, Wan-Seok
发明人： Wan-Seok Han Whayang Bldg., 2nd floor
IPC分类号： A61K35/78 , A23L1/30
CPC分类号： A61K36/815 , A23L33/105 , A61K36/232 , A61K36/284 , A61K36/40 , A61K36/481 , A61K36/484 , A61K36/65 , A61K36/734 , A61K36/758 , A61K2300/00
摘要： Disclosed is a composition for use in health foods for the prophylaxis and treatment of constipation, prepared from medicinal herbs, including Angelica gigas Nakai, Astragalus membranaceus (Fisch.) Bunge, Paeonia aliflora Pallas var. trichocarpa Bunge, Atractylodes japonica (Koidz.) Kitag, Crataegus pinnatifida Bunge, Zanthoxylum piperitum (L.) DC., Lycium chinense Miller, Macrocarpium officinale Sieb. et Zucc., and Glycyrrhiza glabra L. In addition to being safe to the body, the composition exhibits excellent pharmaceutical effects and provide contentment for the user without side effects.
摘要翻译：公开了用于在健康食品用途用于预防和治疗便秘的组合物，从药材，包括当归中井，黄芪（甘草）邦吉，芍药aliflora帕拉斯变种制备。毛果邦吉，关苍术（三叶木。）吴茱萸，山楂邦吉，胡椒木（L.）DC。，枸杞米勒，山茱萸筛。等山茱萸，和甘草L.除了是安全的身体，所述组合物表现出优异的药物的效果和用于无副作用的用户提供满意。

68. 发明公开

EP1180371A1 AGENTS PROMOTING THE FORMATION OF SKIN BASEMENT MEMBRANE, AGENTS PROMOTING THE FORMATION OF ARTIFICIAL SKIN AND PROCESS FOR PRODUCING ARTIFICIAL SKIN 审中-公开
标题翻译： FOR膜皮肤BASIS的教育积极推动下，积极地促进人造皮肤和工艺的培训生产人造皮肤
公开(公告)号：EP1180371A1
公开(公告)日：2002-02-20
申请号：EP01915860.9
申请日：2001-03-27
申请人： SHISEIDO COMPANY LIMITED
发明人： AMANO, S. SHISEIDO RES. CENTER(KANAZAWA HAKKEI) , MATSUNAGA, Y. SHISEIDO RES. CENT.(KANAZAWA HAKKEI) , IN0MATA, S. SHISEIDO RES. CENTER(SHIN-YOKOHAMA)
IPC分类号： A61L27/60 , A61L27/54 , A61K45/00 , A61K38/07 , A61K7/40 , A61K7/48 , A61K7/00 , A61K35/78 , A61K31/44 , A61P17/00
CPC分类号： A61L27/60 , A61K8/64 , A61K31/00 , A61K31/445 , A61K36/65 , A61K36/74 , A61K36/82 , A61K45/06 , A61K2800/782 , A61L27/22 , A61L27/54 , A61L2300/414 , A61L2300/434 , A61Q19/00 , A61K2300/00
摘要： The present invention discloses an artificial skin formation promoting agent and skin basement membrane stabilizing agent comprising matrix metalloproteinase inhibitor or matrix metalloproteinase inhibitor and matrix protein production promoting agent; as well as a production method of artificial skin comprising adding matrix metalloproteinase inhibitor or matrix metalloproteinase inhibitor and matrix protein production promoting agent to an artificial skin formation medium.
摘要翻译：本发明的盘上更少的人造皮肤形成促销廷剂和皮肤基底膜稳定剂，其包含基质金属蛋白酶抑制剂或金属蛋白酶抑制剂和基质蛋白质产生的促销婷剂; 以及人工皮肤包括人造皮肤形成培养基中加入基质金属蛋白酶抑制剂或金属蛋白酶抑制剂和基质蛋白质产生促销婷剂的制造方法。

69. 发明公开

EP0973529A2 ESSENTIAL OIL COMPOSITION 失效
标题翻译：精油LEG STOP END研制
公开(公告)号：EP0973529A2
公开(公告)日：2000-01-26
申请号：EP98909591.4
申请日：1998-03-10
申请人： The Riley Fletcher Foundation
发明人： FLETCHER, Jane, Clarissa , RILEY, Michael, James, Hargreaves
IPC分类号： A61K35/00
CPC分类号： A61K36/481 , A61K8/922 , A61K8/97 , A61K36/14 , A61K36/17 , A61K36/185 , A61K36/23 , A61K36/235 , A61K36/254 , A61K36/258 , A61K36/28 , A61K36/282 , A61K36/284 , A61K36/296 , A61K36/31 , A61K36/324 , A61K36/43 , A61K36/48 , A61K36/484 , A61K36/53 , A61K36/532 , A61K36/535 , A61K36/538 , A61K36/539 , A61K36/54 , A61K36/575 , A61K36/61 , A61K36/65 , A61K36/69 , A61K36/738 , A61K36/74 , A61K36/752 , A61K36/79 , A61K36/804 , A61K36/815 , A61K36/882 , A61K36/886 , A61K36/889 , A61K36/8965 , A61K36/8968 , A61K36/8988 , A61K36/899 , A61Q13/00 , A61Q19/00 , A61Q19/06 , A61K2300/00
摘要： The application relates to new medicinal and cosmetic compositions comprising essential oils in combination with herbs and/or spices. The compositions may be used orally or topically.

70. 发明申请

US20180028591A1 MALE AND FEMALE INFERTILITY HERBAL COMPOSITION 审中-公开
公开(公告)号：US20180028591A1
公开(公告)日：2018-02-01
申请号：US15224991
申请日：2016-08-01
申请人： Shaobin Ke
发明人： Shaobin Ke
IPC分类号： A61K36/9066 , A61K36/537 , A61K36/752 , A61K36/70 , A61K36/296 , A61K36/185 , A61K36/73 , A61K36/481 , A61K36/8945 , A61K36/65 , A61K36/28 , A61K36/605 , A61K36/39 , A61K36/344
CPC分类号： A61K36/9066 , A61K36/185 , A61K36/28 , A61K36/296 , A61K36/344 , A61K36/39 , A61K36/481 , A61K36/537 , A61K36/605 , A61K36/65 , A61K36/70 , A61K36/73 , A61K36/752 , A61K36/8945 , A61K2236/00 , A61K2300/00
摘要： An herbal composition that enhances and promotes fertility in both males and females by nourishing the kidney, regulating the liver and spleen, improving circulation of Qi and blood, and balancing the Yin and Yang through a unique composition consisting of natural herbs known in traditional Chinese medicine. The herbs create a synergy between each other that works to enhance fertility for both males and females. The composition consists of the following herbal ingredients mixed in varying weight percentages. goji berry, dodder seed, red sage root, green orange peel, processed fleece flower root, horny goat weed, codonopsis, raspberry, astragalus root, Chinese yam, white peony root, false daisy, mulberry, curcuma tuber, and cynomorium. The herbal ingredients are cleaned, purified and/or processed prior to formulation. The formulation process is at least partially dependent on the desired means of preparation and administering the composition.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式